000			02334 a2200625 4500
005			20250518071226.0
264		0	_c20200106
008			202001s 0 0 eng d
022			_a1474-547X
024	7		_a10.1016/S0140-6736(19)32556-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aAttal, Michel
245	0	0	_aIsatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study. _h[electronic resource]
260			_bLancet (London, England) _c12 2019
300			_a2096-2107 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Video-Audio Media
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aAsia
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aEurope
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aNorth America
650	0	4	_aProgression-Free Survival
650	0	4	_aThalidomide _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aRichardson, Paul G
700	1		_aRajkumar, S Vincent
700	1		_aSan-Miguel, Jesus
700	1		_aBeksac, Meral
700	1		_aSpicka, Ivan
700	1		_aLeleu, Xavier
700	1		_aSchjesvold, Fredrik
700	1		_aMoreau, Philippe
700	1		_aDimopoulos, Meletios A
700	1		_aHuang, Jeffrey Shang-Yi
700	1		_aMinarik, Jiri
700	1		_aCavo, Michele
700	1		_aPrince, H Miles
700	1		_aMacé, Sandrine
700	1		_aCorzo, Kathryn P
700	1		_aCampana, Frank
700	1		_aLe-Guennec, Solenn
700	1		_aDubin, Franck
700	1		_aAnderson, Kenneth C
773	0		_tLancet (London, England) _gvol. 394 _gno. 10214 _gp. 2096-2107
856	4	0	_uhttps://doi.org/10.1016/S0140-6736(19)32556-5 _zAvailable from publisher's website
999			_c30321174 _d30321174